About the Division of Gastroenterology

The mission of the Dr. Henry D. Janowitz Division of Gastroenterology at Mount Sinai is excellence in the delivery of patient care, research, and education in diseases of the GI tract. For more than a century, Mount Sinai gastroenterologists, surgeons, pathologists, and experts in related clinical and research areas have been at the forefront of innovation, shaping the future of GI medicine and clinical practice. Our pioneering work has led to advances in the diagnosis, treatment, and management of inflammatory bowel disease, peptic ulcer disease, esophageal disorders, gastrointestinal cancers, and pancreatic and biliary diseases.

To achieve its mission, the Division of Gastroenterology has developed continually expanding, world-leading digestive disease centers of excellence that include the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center and the GI Motility Center. Each center, with its distinct subspecialty and focus area, allows us to further the science of gastroenterology on several fronts and keeps us at the cutting edge of delivering the highest quality of patient care. Other programs of excellence include advanced colonoscopy and therapeutic endoscopy services and pancreatic cancer.

The Division of Gastroenterology at The Mount Sinai Hospital was recently ranked No. 1 in New York by Newsweek for 2024 and No. 6 in the United States by U.S. News & World Report® for 2023-24.

System Chief: Bruce E. Sands, MD, MS
Dr. Burrill B. Crohn Professor of Medicine